DE69831522D1 - In-situ Zellextraktion und Assay-Verfahren - Google Patents

In-situ Zellextraktion und Assay-Verfahren

Info

Publication number
DE69831522D1
DE69831522D1 DE69831522T DE69831522T DE69831522D1 DE 69831522 D1 DE69831522 D1 DE 69831522D1 DE 69831522 T DE69831522 T DE 69831522T DE 69831522 T DE69831522 T DE 69831522T DE 69831522 D1 DE69831522 D1 DE 69831522D1
Authority
DE
Germany
Prior art keywords
cell extraction
assay procedures
situ cell
situ
assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69831522T
Other languages
English (en)
Other versions
DE69831522T2 (de
Inventor
Dr Horton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare UK Ltd
Original Assignee
Amersham Biosciences UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9715704.4A external-priority patent/GB9715704D0/en
Application filed by Amersham Biosciences UK Ltd filed Critical Amersham Biosciences UK Ltd
Application granted granted Critical
Publication of DE69831522D1 publication Critical patent/DE69831522D1/de
Publication of DE69831522T2 publication Critical patent/DE69831522T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869—Interleukin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
DE69831522T 1997-03-03 1998-02-18 In-situ Zellextraktion und Assay-Verfahren Expired - Lifetime DE69831522T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97301398 1997-03-03
GBGB9715704.4A GB9715704D0 (en) 1997-07-24 1997-07-24 In-situ cell extraction and assay method

Publications (2)

Publication Number Publication Date
DE69831522D1 true DE69831522D1 (de) 2005-10-20
DE69831522T2 DE69831522T2 (de) 2006-06-14

Family

ID=26147318

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69831522T Expired - Lifetime DE69831522T2 (de) 1997-03-03 1998-02-18 In-situ Zellextraktion und Assay-Verfahren

Country Status (6)

Country Link
US (1) US6900019B1 (de)
EP (1) EP0863402B1 (de)
JP (1) JP4012301B2 (de)
CA (1) CA2230423C (de)
DE (1) DE69831522T2 (de)
ES (1) ES2246522T3 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69935850T2 (de) * 1998-02-16 2008-01-10 Ge Healthcare Uk Ltd., Little Chalfont Verfahren zur messung der gesamkonzentration eines analytes
US7319021B2 (en) * 2002-11-01 2008-01-15 Promega Corporation Cell lysis composition, methods of use, apparatus and kit
WO2004099384A2 (en) * 2003-05-02 2004-11-18 Sigma-Aldrich Co. Solid phase cell lysis and capture platform
WO2007082181A2 (en) 2006-01-10 2007-07-19 Colgate-Palmolive Company Methods of modulating cell surface receptors to prevent or reduce inflammation
GB0800938D0 (en) * 2008-01-18 2008-02-27 Ge Healthcare Uk Ltd Multiplex cell signalling assay
JP6479663B2 (ja) 2012-10-08 2019-03-06 ビーエル テクノロジーズ、インコーポレイテッド Ｌａｌ反応性物質を試験するための予充填試験基板、使用方法及び作製方法
WO2016099999A1 (en) * 2014-12-18 2016-06-23 Ge Healthcare Uk Limited Analyte detection on a solid support by nucleic acid amplification coupled to an immunoassay

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1604249A (en) 1977-05-31 1981-12-02 Kolehmainen S Selective measurement of somatic and microbial cells
US4568649A (en) 1983-02-22 1986-02-04 Immunex Corporation Immediate ligand detection assay
US5185432A (en) 1986-02-26 1993-02-09 Oncogen Monoclonal antibodies and antigen for human non-small cell lung carcinoma and other certain human carcinomas
US4956274A (en) 1987-04-06 1990-09-11 Microgenics Corporation Reagent stabilization in enzyme-donor and acceptor assay
EP0301847A1 (de) 1987-07-29 1989-02-01 Microgenics Corporation Reinigung unter Verwendung von Cyclodextrin
GB8722252D0 (en) * 1987-09-22 1987-10-28 Brewing Res Found Atp extraction
US5268299A (en) 1988-04-14 1993-12-07 Eastman Kodak Company Diluent composition useful in the detection of antibodies in assays
US5032503A (en) * 1988-06-22 1991-07-16 Microgenics Corporation Liquid single reagent for air enzyme complementation assay
SE8803602D0 (sv) 1988-10-11 1988-10-11 Wallac Oy A sample plate with a plurality of sample wells or vials intended for radiolabeled binding assays
US5705345A (en) * 1991-01-10 1998-01-06 Amersham International Plc Methods and kits for preparing nucleic acids using cyclodextrin
GB9100551D0 (en) * 1991-01-10 1991-02-20 Amersham Int Plc Method and reagent for eliminating analytical interference in enzymatic analysis from substances used for extraction of intracellular metabolites
JP3152933B2 (ja) 1993-05-17 2001-04-03 アマーシャム・インターナショナル・ピーエルシー 細胞生化学プロセスを測定するための装置および方法
CA2239957A1 (en) * 1995-12-22 1997-07-03 Abbott Laboratories Fluorescence polarization immunoassay diagnostic method
US5739001A (en) 1996-10-29 1998-04-14 E. I. Du Pont De Nemours And Company Solid phase cell-based assay

Also Published As

Publication number Publication date
US6900019B1 (en) 2005-05-31
DE69831522T2 (de) 2006-06-14
EP0863402A2 (de) 1998-09-09
JP4012301B2 (ja) 2007-11-21
JPH10253630A (ja) 1998-09-25
ES2246522T3 (es) 2006-02-16
CA2230423A1 (en) 1998-09-03
CA2230423C (en) 2007-02-06
EP0863402A3 (de) 1999-07-21
EP0863402B1 (de) 2005-09-14

Similar Documents

Publication Publication Date Title
DE69841509D1 (de) Lektrodenfomstück und elektrochemische elemente
DE69832657D1 (de) Empfangseinrichtungen und Empfangsverfahren
DE69835254D1 (de) Empfangseinrichtungen und Empfangsverfahren
DE69803199T2 (de) Erkennung und entfernung von makroviren
DE69826338D1 (de) Sicherheitsrückhalt
DE69831615D1 (de) Brennstoffzelle und Separator
DE69738197D1 (de) Azolotriazine und pyrimidine
ID26599A (id) Turunan triazola dan imidazola
DE69839754D1 (de) Kurzzellenmultiplexer
ID23173A (id) Turunan pirol trisiklik atau pirazol
DE69818488D1 (de) Sammelbehälter
DE69840500D1 (de) Mutierte alpha-amylasen
DE69916694D1 (de) 2-Hydroxy-5-methyl-hexan-3-on und 3-hydroxy-5-methyl-hexan-2-on
DE69737627D1 (de) Analysezelle
DE69831522T2 (de) In-situ Zellextraktion und Assay-Verfahren
DE29714130U1 (de) Zerkleinerungsvorrichtung
DE59805515D1 (de) Asservations- und auffangvorrichtung
DE69842206D1 (de) Echounterdrücker und echounterdrückungsverfahren
DE69814442D1 (de) Strukturerkennung
GB9704162D0 (en) Assay methods and means
GB9813778D0 (en) Assay methods and means
DE29718512U1 (de) Zerkleinerungsvorrichtung
DE29702903U1 (de) Schachteinrichtung und Herstellungsvorrichtung
DE29716642U1 (de) Trenn- und Abscheidevorrichtung
DE29717607U1 (de) Misch- und Zerkleinerungsvorrichtung

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Representative=s name: HAMMONDS RECHTSANWAELTE PATENTANWAELTE, 80539 MUENCHEN

8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: GE HEALTHCARE UK LTD., LITTLE CHALFONT, BUCKINGHAM

8328 Change in the person/name/address of the agent

Representative=s name: HAMMONDS LLP, LONDON, GB

R082 Change of representative

Ref document number: 863402

Country of ref document: EP

Representative=s name: J D REYNOLDS & CO., GB